CIK 0001528172
- Non-accelerated filer
- Smaller reporting company
ENDONOVO THERAPEUTICS, INC.
Sign in to watch- Ticker
- ENDV
- Exchange
- OTC
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 452552528
- Phone
- +1 800-489-4774
- Business address
- 6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
- Former names
- Hanover Portfolio Acquisitions, Inc.
- 4 Open-market buy President bought 9,000 shares at an average $0.05 ($483)
- 4 Open-market buy President bought 8,000 shares at an average $0.06 ($471)
- 4 Open-market buy President bought 23,000 shares at an average $0.06 ($1,320)
- 4 Open-market buy President bought 6,000 shares at an average $0.06 ($346)
- 4 Open-market buy President bought 29,200 shares at an average $0.05 ($1,451)
- 4 Open-market buy President bought 15,800 shares at an average $0.02 ($251)
- 4 Open-market buy President bought 14,300 shares at an average $0.01 ($181)
- 4 Open-market buy President bought 20,100 shares at an average $0.01 ($278)
- 4 Open-market buy President bought 25,100 shares at an average $0.02 ($598)
- 4 Open-market buy President bought 16,900 shares at an average $0.03 ($559)
- 4 Open-market buy President bought 30,400 shares at an average $0.03 ($1,018)
- 4 Open-market buy President bought 19,200 shares at an average $0.05 ($932)
- 4 Open-market buy President bought 12,934 shares at an average $0.04 ($553)
- 4 Open-market buy President bought 7,800 shares at an average $0.05 ($396)
- 4 Open-market buy President bought 8,600 shares at an average $0.05 ($452)
- 4 Open-market buy President bought 200 shares at $0.06 ($12)
- 4 Open-market buy president bought 23,700 shares at an average $5.12 ($121,283)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President bought 5,922 shares at an average $0.08 ($494)
- 4 Open-market buy President bought 3,800 shares at an average $0.09 ($334)
Page 15 of 16 · 306 filings